Report DMCA MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.